124 related articles for article (PubMed ID: 11215204)
1. [MN/CA IX antigen as a potential target for renal cell carcinoma].
Uemura H; Cho M; Nakagawa Y; Shimizu K; Yoshikawa M; Kim S; Hirao Y
Hinyokika Kiyo; 2000 Oct; 46(10):745-8. PubMed ID: 11215204
[TBL] [Abstract][Full Text] [Related]
2. [The role of MN/CA IX antigen in carcinogenesis and metastasis of renal cell carcinoma].
Nakagawa Y; Uemura H; Shimizu K; Cho M; Yoshikawa M; Hirao Y; Yoshikawa K
Hinyokika Kiyo; 2001 Nov; 47(11):809-14. PubMed ID: 11771176
[TBL] [Abstract][Full Text] [Related]
3. MN/CA IX/G250 as a potential target for immunotherapy of renal cell carcinomas.
Uemura H; Nakagawa Y; Yoshida K; Saga S; Yoshikawa K; Hirao Y; Oosterwijk E
Br J Cancer; 1999 Oct; 81(4):741-6. PubMed ID: 10574265
[TBL] [Abstract][Full Text] [Related]
4. The expression of G250/mn/CA9 antigen by flow cytometry: its possible implication for detection of micrometastatic renal cancer cells.
Li G; Passebosc-Faure K; Lambert C; Gentil-Perret A; Blanc F; Oosterwijk E; Mosnier JF; Genin C; Tostain J
Clin Cancer Res; 2001 Jan; 7(1):89-92. PubMed ID: 11205923
[TBL] [Abstract][Full Text] [Related]
5. [Molecular detection of circulating cancer cells in patients with renal cell carcinoma].
Uemura H
Hinyokika Kiyo; 1999 Aug; 45(8):571-5. PubMed ID: 10500965
[TBL] [Abstract][Full Text] [Related]
6. Detection of circulating MN/CA9 positive renal cell carcinoma cells during operation.
Uemura H; Nakagawa Y; Iwai A; Okajima E; Okajima E; Yoshikawa K; Hirao Y
Aktuelle Urol; 2003 Jul; 34(4):270-2. PubMed ID: 14566683
[TBL] [Abstract][Full Text] [Related]
7. Identification of the MN/CA9 protein as a reliable diagnostic biomarker of clear cell carcinoma of the kidney.
Liao SY; Aurelio ON; Jan K; Zavada J; Stanbridge EJ
Cancer Res; 1997 Jul; 57(14):2827-31. PubMed ID: 9230182
[TBL] [Abstract][Full Text] [Related]
8. The use of MN/CA9 gene expression in identifying malignant solid renal tumors.
Li G; Cuilleron M; Cottier M; Gentil-Perret A; Lambert C; Genin C; Tostain J
Eur Urol; 2006 Feb; 49(2):401-5. PubMed ID: 16387417
[TBL] [Abstract][Full Text] [Related]
9. The detection of renal carcinoma cells in the peripheral blood with an enhanced reverse transcriptase-polymerase chain reaction assay for MN/CA9.
McKiernan JM; Buttyan R; Bander NH; de la Taille A; Stifelman MD; Emanuel ER; Bagiella E; Rubin MA; Katz AE; Olsson CA; Sawczuk IS
Cancer; 1999 Aug; 86(3):492-7. PubMed ID: 10430258
[TBL] [Abstract][Full Text] [Related]
10. Hypomethylation of the MN/CA9 promoter and upregulated MN/CA9 expression in human renal cell carcinoma.
Cho M; Uemura H; Kim SC; Kawada Y; Yoshida K; Hirao Y; Konishi N; Saga S; Yoshikawa K
Br J Cancer; 2001 Aug; 85(4):563-7. PubMed ID: 11506497
[TBL] [Abstract][Full Text] [Related]
11. Activation of the MN/CA9 gene is associated with hypomethylation in human renal cell carcinoma cell lines.
Cho M; Grabmaier K; Kitahori Y; Hiasa Y; Nakagawa Y; Uemura H; Hirao Y; Ohnishi T; Yoshikawa K; Ooesterwijk E
Mol Carcinog; 2000 Mar; 27(3):184-9. PubMed ID: 10708480
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the CA9 promoter can modulate expression of the tumor-associated carbonic anhydrase IX in dense carcinoma cell lines.
Jakubicková L; Biesová Z; Pastoreková S; Kettmann R; Pastorek J
Int J Oncol; 2005 Apr; 26(4):1121-7. PubMed ID: 15754010
[TBL] [Abstract][Full Text] [Related]
13. A potential for tissue restrictive gene therapy in renal cell carcinoma using MN/CA IX promoter.
Ou YC; Gardner TA; Kao C; Zhau HE; Chung LW
Anticancer Res; 2005; 25(2A):881-6. PubMed ID: 15868923
[TBL] [Abstract][Full Text] [Related]
14. MN/CA9 gene expression as a potential biomarker in renal cell carcinoma.
Murakami Y; Kanda K; Tsuji M; Kanayama H; Kagawa S
BJU Int; 1999 May; 83(7):743-7. PubMed ID: 10368188
[TBL] [Abstract][Full Text] [Related]
15. MN/CA9 gene expression as a potential tumor marker for renal cell carcinoma.
Raina P; Singh SK; Goswami AK; Kashyap MK; Khullar M; Sharma SK; Barwal KC
Mol Cell Biochem; 2022 Feb; 477(2):333-343. PubMed ID: 34716861
[TBL] [Abstract][Full Text] [Related]
16. Quantification of G250 mRNA expression in renal epithelial neoplasms by real-time reverse transcription-PCR of dissected tissue from paraffin sections.
Bismar TA; Bianco FJ; Zhang H; Li X; Sarkar FH; Sakr WA; Grignon DJ; Che M
Pathology; 2003 Dec; 35(6):513-7. PubMed ID: 14660102
[TBL] [Abstract][Full Text] [Related]
17. [Detection of carbonic anhydrase IX gene expression in renal cell carcinoma with reverse transcription-PCR].
Jiang YD; Zheng SB; Wang ZH
Di Yi Jun Yi Da Xue Xue Bao; 2004 Jan; 24(1):99-101. PubMed ID: 14724112
[TBL] [Abstract][Full Text] [Related]
18. [Value of MN/CAIX in the diagnosis of renal cell carcinoma].
Jiang YD; Ren F; Zheng SB
Nan Fang Yi Ke Da Xue Xue Bao; 2012 Mar; 32(3):412-4. PubMed ID: 22445996
[TBL] [Abstract][Full Text] [Related]
19. Effects of von Hippel-Lindau gene mutation and methylation status on expression of transmembrane carbonic anhydrases in renal cell carcinoma.
Ashida S; Nishimori I; Tanimura M; Onishi S; Shuin T
J Cancer Res Clin Oncol; 2002 Oct; 128(10):561-8. PubMed ID: 12384800
[TBL] [Abstract][Full Text] [Related]
20. Expression of the tumor-associated gene MN: a potential biomarker for human renal cell carcinoma.
McKiernan JM; Buttyan R; Bander NH; Stifelman MD; Katz AE; Chen MW; Olsson CA; Sawczuk IS
Cancer Res; 1997 Jun; 57(12):2362-5. PubMed ID: 9192809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
